University of Maryland School of Medicine Launches Vaccine Development Program to Prevent Sepsis in Newborns
University of Maryland School of MedicineUniversity of Maryland School of Medicine (UMSOM) researchers at the Center for Vaccine Development and Global Health (CVD) have been awarded $3.96 million to develop a maternal vaccine that prevents sepsis caused by Klebsiella pneumoniae in newborns and infants.